A Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) With Inadequate Response to Standard of Care (SOC) Therapy
Details
Age
Adult
Type of Study
Treatment
Locations
Barbara Davis Center
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Christopher Striebich, MD, PhD
Study ID
Protocol Number: 20-0094
More information available at ClinicalTrials.gov: NCT04058028
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers